Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06QBY
|
|||
| Former ID |
DNCL002868
|
|||
| Drug Name |
INT131
|
|||
| Synonyms |
C541917000
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [1] | |
| Company |
InteKrin Therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H12Cl4N2O3S
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C=C(C=N2)OC3=C(C=C(C=C3Cl)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl)Cl
|
|||
| InChI |
1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H
|
|||
| InChIKey |
NMRWDFUZLLQSBN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 315224-26-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00631007) A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.